Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

New Haven, Connecticut 06511


Purpose:

The purpose of this study is the following: - To determine the safety and tolerability of single ascending intravenous (IV) doses of PF-05230907 in healthy Japanese subjects. - To characterize the PK profile of single ascending IV doses of PF-05230907 in healthy Japanese subjects. - To characterize the PD profiles of single ascending IV doses of PF-05230907 in healthy Japanese subjects. - To evaluate the immunogenicity of PF-05230907 in healthy Japanese subjects


Criteria:

Inclusion Criteria: - Healthy male of females - Body Mass Index (BMI) of 17.5 to 30.5 kg/m2; and a total body weight >50 kg (110 lbs) and <120 kg (265 lbs). - Japanese subjects who have four biologic Japanese grandparents born in Japan. Exclusion Criteria: - Pregnant or nursing females. - Females of childbearing potential who are unwilling or unable to use an acceptable method of contraception. - Evidence or history of clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or allergic disease


NCT ID:

NCT02537002


Primary Contact:

Study Director
Pfizer CT.gov Call Center
Pfizer


Backup Contact:

N/A


Location Contact:

New Haven, Connecticut 06511
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 18, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.